Clinical Trial Update: Efficacy and Safety Study of DERMAGEN® vs Conventional Treatment to Treat Diabetic Neuropathic Foot Ulcer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating DERMAGEN versus conventional treatment for diabetic neuropathic foot ulcers, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Diabetic Foot Ulcer

Drugs mentioned

• DERMAGEN

Snippet

Sponsor: Laboratoires Genévrier | Conditions: Diabetes, Foot Ulcer | Phase 3 | Status: UNKNOWN